Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Pre-order your Brochure
Reserve your place

Back for an 8th year, eyeforpharma’s Oncology Market Access & Pricing Summit brings together all stakeholders, including pharma, insurance companies, patient advocacy groups, and cancer associations to bridge the gap on the differing views of “value”.

Pre-order the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown

Co-chaired by Aetna’s Michael Kolodziej, the 2016 conference was seen as the most targeted and high-level gathering on commercialization of cancer products in the US.

150+ senior executives attended, including the following leading oncology innovators:



  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee

Why attend?

  • Value-Based Pricing Metrics Round Robin - Hear why payers are hungry for these models, how they may leverage them, and which metrics will make a significant impact on the market access environment
  • Determine How to Best Position Your Brand in an Evolving Market - Work cross-functionally with teams to address the challenges these metrics bring to develop a stronger market access trajectory by better demonstrating your products’ importance.
  • Prepare for Stakeholder’s Demands - Adopt new business strategies that effectively generate, manage, and apply relevant health economic and clinical data from drug development through reimbursement
  • Set Your Brand Apart in the Changing Payment Model Landscape - Decipher how potential APMs may impact your products and determine which are likely to have significant risks for the adoption of innovative drugs and biologics

Our 2016 Speaker Line-Up

William Hinshaw
William Hinshaw

Novartis

Executive VP, US Oncology

Michael Ryan
Michael Ryan

Bristol-Myers Squibb

SVP US Value, Access, & Policy

Anil Kapur
Anil Kapur

Baxalta

VP & Global Head of Oncology Commercial

Anna Forsythe
Anna Forsythe

Eisai

Senior Director & Head of Global Value & Access

Richard Schilsky
Richard Schilsky

ASCO

CMO

Michael Kolodziej
Michael Kolodziej

Aetna

National Medical Director

Our Track-Record of Proven Success

83%

call our sessions essential

94%

said they will likely return again next year

97%

rated the program very well run

What our Delegates are saying

Pre-order the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown